Live Quote · NASDAQRPRXHealthcare· Medical - Pharmaceuticals

Royalty Pharma plc

$58.18▼ 0.60%($-0.35)
TickerSpark Score
84/100
▌ Strong
72
Valuation
90
Profitability
75
Growth
84
Health
100
Momentum

Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a RPRX research report →

52-Week Range95% of range
Low
$34.08
Current
$58.18
High
$59.44
Company Overviewwww.royaltypharma.com

About the company

Royalty Pharma plc operates as a buyer of biopharmaceutical royalties and a funder of innovation in the biopharmaceutical industry in the United States. Its portfolio consists of royalties on approximately 35 marketed therapies and 20 development-stage product candidates that address various therapeutic areas, such as rare disease, oncology, neuroscience, infectious disease, hematology, and diabetes. The company was founded in 1996 and is based in New York, New York.

CEO
Pablo Legorreta
IPO
2020
Employees
100
HQ
New York, NY, US

Price Chart

+64.03% · this period
$58.53$46.72$34.90Jul 17Jan 15Jul 17

Get TickerSpark's AI analysis on RPRX

Create an account to generate AI analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.

Get Pro Access →

Already have an account? Log in